Enteromedics Inc (ETRM)

[Ned Serious]

EnteroMedics is Favorite Idea for 2014 by Lake Street

January 3, 2014

In a report published Friday, Lake Street Capital Markets analyst Bruce Jackson rated EnteroMedics as the favorite idea for 2014.

Jackson reported that EnteroMedics is best positioned to benefit from several near-term trends. The analyst commented, “First, the current macro favors companies whose products address unmet treatment needs while making healthcare delivery more efficient and effective. Second, we see a continued improving environment for growth stocks and small-caps in 2014 as the Fed begins to taper and the yield curve should steepen. Third, small caps like ETRM should also continue to benefit from acquisition activity as large companies with strong balance sheets deploy cash in search of new growth.”

Lake Street anticipates that the company will shortly obtain an FDA panel date for the VBLOC obesity treatment device, which should take place at the end of the first quarter. In addition, Jackson noted that positive clinical data for new drugs, licensing deals, and potential M&A activity aided the healthcare sector in leading the broader market indices for all market cap segments in 2013. The analyst continued, commenting that investors are beginning to pursue higher-growth segments within Healthcare and specifically noted that Healthcare Information Technology moved up “in the anticipation of major changes being made to the healthcare payment systems in the United States.”


Link: http://www.benzinga.com/analyst-ratings/analyst-color/14/01/4191439/enteromedics-is-favorite-idea-for-2014-by-lake-street#ixzz2pU5Smq2f

Author Bio:
Bruce is a senior healthcare research analyst with more than twenty years of experience both on and off Wall Street. He focuses on companies poised to benefit from changes in the healthcare system and the drive for better patient outcomes at lower cost. In May, 2011, Bruce received an FT/StarMine Analyst Award for being the Number 1 stock picker in Health Care Equipment and Supplies and was named a Wall Street Journal All-Star for stock picking in Health Equipment & Supplies. Prior to becoming a Wall Street analyst, he served with Abbott Laboratories as a Project Manager in the Hospital Products Division, and as a Market Planner in the Abbott Diagnostics Division. Bruce began his Wall Street career at Vector Securities and has held senior analyst positions at Wachovia, RBC, Morgan Joseph TriArtisan, and Northland Securities. Bruce received a BA degree from University of Wisconsin and an MBA in General Management from the Johnson Graduate School of Management at Cornell University.

Lake Street Link: http://www.lakestreetcapitalmarkets.com/Approach/Lake-Street-Team/36